Mark J. Foley, CEO: Revance Therapeutics RVNC Buy · Filed 24/03/08

Trade details

Type: Insider buy
Amount: $209,400
Shares · price: 30,000 sh · $6.98 a share
Held after: 1,015,468 sh
Stock: Revance Therapeutics RVNC
Person: Mark J. FoleyCEO
Trade date: 24/03/06
Filed: 24/03/08
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +3.0%

Revance Therapeutics trades, last 26 weeks

What else happened in Revance Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/05~24/04/05

Mark J. Foley's recent trades

Mark J. FoleyDirector
SellGlaukos
Sell
Glaukos
GKOS
$2.5M
20,687 sh
$2.5M
Filed 25/02/28
Traded 25/02/26
Mark J. FoleyDirector
Planned saleGlaukos
Planned sale
Glaukos
GKOS
$2.5M
20,687 sh
$2.5M
Filed 25/02/26
Traded 25/02/26
Mark J. FoleyDirector
SellGlaukos
Sell
Glaukos
GKOS
$423.5K
4,560 sh
$423.5K
Filed 24/02/26
Traded 24/02/23
Mark J. FoleyCEO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$593.1K
26,279 sh
$593.1K
Filed 23/08/04
Traded 23/08/03
Mark J. FoleyCEO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$655.4K
26,279 sh
$655.4K
Filed 23/07/05
Traded 23/07/03